⌘K

Login Start Free

Home/Insiders/Asanuma Sakae

AS

SEC Insider//CIK 0001857822

Asanuma Sakae

CIK 00018578221 companyCAMBRIDGE, MA

Transactions

6

Companies

1

Filings

1

CIK

0001857822

Recent Transactions

6 trades

Conversion
Werewolf Therapeutics, Inc.$HOWL
Common Stock
2021-05-04+1,318,311→ 1,318,311 total
Conversion
Werewolf Therapeutics, Inc.$HOWL
Common Stock
2021-05-04+438,098→ 1,756,409 total
Purchase
Werewolf Therapeutics, Inc.$HOWL
Common Stock
2021-05-04$16.00/sh+312,500→ 2,068,909 total
Conversion
Werewolf Therapeutics, Inc.$HOWL
Series B Preferred Stock
2021-05-04−3,797,921→ 0 total
Conversion
Werewolf Therapeutics, Inc.$HOWL
Series A Preferred Stock
2021-05-04−11,428,570→ 0 total
Purchase
Werewolf Therapeutics, Inc.$HOWL
Series B Preferred Stock
2020-12-23$0.92/sh+3,797,921→ 3,797,921 total

Companies

1

Werewolf Therapeutics, Inc.
Director, 10% Owner
$HOWL

Recent Filings

1

4
Asanuma Sakae
May 4, 2021

Address

C/O WEREWOLF THERAPEUTICS, INC. 1030 MASSACHUSETTS AVENUE, SUITE 210

CAMBRIDGE, MA, 02138

View on SEC.gov